Publications by authors named "Ronald Verrall"

Claim this Profile
D
Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
Waleed Mohammed-Saeid, Rania Soudy, Richa Tikoo, Kamaljit Kaur, Ronald E Verrall

J Pharm Pharm Sci· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion Complexes of Melphalan with Gemini-Conjugated β-Cyclodextrin: Physicochemical Properties and Chemotherapeutic Efficacy in In-Vitro Tumor Models.
Waleed Mohammed-Saeid, Abdalla H Karoyo, Ronald E Verrall, Lee D Wilson, Ildiko Badea

Pharmaceutics· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants.
Mays Al-Dulaymi, Deborah Michel, Jackson M Chitanda, Anas El-Aneed, Ronald E Verrall

Bioconjug Chem· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
Waleed Mohammed-Saeid, Jackson Chitanda, Mays Al-Dulaymi, Ronald Verrall, Ildiko Badea

Pharm Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models.
Deborah Michel, Waleed Mohammed-Saeid, Heather Getson, Caitlin Roy, Masoomeh Poorghorban, Ronald Verrall

Int J Nanomedicine· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity.
Mays A Al-Dulaymi, Jackson M Chitanda, Waleed Mohammed-Saeid, Hessamaddin Younesi Araghi, Ronald E Verrall

AAPS J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application.
Saniya Alwani, Randeep Kaur, Deborah Michel, Jackson M Chitanda, Ronald E Verrall

Int J Nanomedicine· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
Masoomeh Poorghorban, Umashankar Das, Osama Alaidi, Jackson M Chitanda, Deborah Michel, Ronald Verrall

Int J Nanomedicine· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of phospholipids on plasmid packaging and toxicity of gemini nanoparticles.
Chilbert Dong, Ildiko Badea, Masoomeh Poorghorban, Ronald Verrall, Marianna Foldvari

J Mater Chem B· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 1H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant.
Masoomeh Poorghorban, Abdalla H Karoyo, Pawel Grochulski, Ronald E Verrall, Lee D Wilson

Mol Pharm· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of amino acid substituted gemini surfactant-based mucoadhesive gene delivery systems for potential use as noninvasive vaginal genetic vaccination.
Jagbir Singh, Deborah Michel, Heather M Getson, Jackson M Chitanda, Ronald E Verrall

Nanomedicine (Lond)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.
Joshua Buse, Randy W Purves, Ronald E Verrall, Ildiko Badea, Haixia Zhang

J Mass Spectrom· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-stage tandem mass spectrometric analysis of novel β-cyclodextrin-substituted and novel bis-pyridinium gemini surfactants designed as nanomedical drug delivery agents.
McDonald Donkuru, Jackson M Chitanda, Ronald E Verrall, Anas El-Aneed

Rapid Commun Mass Spectrom· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Waleed Mohammed-Saeid, Deborah Michel, Anas El-Aneed, Ronald E Verrall, Nicholas H Low

J Pharm Pharm Sci· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A general liquid chromatography tandem mass spectrometry method for the quantitative determination of diquaternary ammonium gemini surfactant drug delivery agents in mouse keratinocytes' cellular lysate.
Joshua Buse, Ildiko Badea, Ronald E Verrall, Anas El-Aneed

J Chromatogr A· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies.
Randeep Kaur, Jackson M Chitanda, Deborah Michel, Jason Maley, Ferenc Borondics, Ronald E Verrall

Int J Nanomedicine· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma.
Deborah Michel, Jackson M Chitanda, Réka Balogh, Peng Yang, Jagbir Singh, Ronald Verrall

Eur J Pharm Biopharm· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Jagbir Singh, Deborah Michel, Jackson M Chitanda, Ronald E Verrall, Ildiko Badea

J Nanobiotechnology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem mass spectrometric analysis of novel diquaternary ammonium gemini surfactants and their bromide adducts in electrospray-positive ion mode ionization.
Joshua Buse, Ildiko Badea, Ronald E Verrall, Anas El-Aneed

J Mass Spectrom· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.
Jagbir Singh, Peng Yang, Deborah Michel, Ronald E Verrall, Marianna Foldvari

Curr Drug Deliv· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.
McDonald Donkuru, Ildiko Badea, Shawn Wettig, Ronald Verrall, Mahmoud Elsabahy

Nanomedicine (Lond)· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles.
Peng Yang, Jagbir Singh, Shawn Wettig, Marianna Foldvari, Ronald E Verrall

Eur J Pharm Biopharm· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions between adsorbed layers of cationic gemini surfactants.
Eva Blomberg, Ronald Verrall, Per M Claesson

Langmuir· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemini surfactants: a new family of building blocks for non-viral gene delivery systems.
Shawn D Wettig, Ronald E Verrall, Marianna Foldvari

Curr Gene Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
Shawn D Wettig, Ildiko Badea, McDonald Donkuru, Ronald E Verrall, Marianna Foldvari

J Gene Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis